Mobile

An open label randomised controlled study in elderly subjects with previously untreated acute myelogenous leukaemia, comparing treatment groups randomised to receive daunorubicin and cytarabine or dau...

Mise à jour : Il y a 4 ans
Référence : ISRCTN11571826

An open label randomised controlled study in elderly subjects with previously untreated acute myelogenous leukaemia, comparing treatment groups randomised to receive daunorubicin and cytarabine or daunorubicin, cytarabine and PSC-833

Femme et Homme

  • | Pays :
  • Netherlands
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Not provided at time of registration

Critère d'inclusion

  • Acute Myeloid Leukaemia (AML)

Liens